Investor insights
Sectors invested in
Biotechnology4
Medical3
Pharmaceutical3
Precision Data1
Artificial Intelligence1
Health Care1
Image Management1
Tissue Microarrays1
NAFLD1
Deep Learning1
Digital Pathology1
Whole Slide Imaging1
Diagnostics1
Image Analysis1
Antibody Validation1
Biomarker Quantification1
Multi-Scale Omics1
Oncology1
In Situ Hybridization1
NASH1
Funding rounds participated in
$20M sweet spot round size
Most of their 4 investments are in rounds between $5M and $35M
Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Hydronidone
Targeted Protein Degradation
Japan
China
Pharmaceutical
Manufacturing
Pirfenidone
US
Date founded
2001
Investments made
C
Cullgen Inc. raised $5M on May 8, 2023
Investors: GNI Group Ltd.
C
Cullgen Inc. raised $35M on May 8, 2023
Investors: Sincere Capital, 无锡市金融投资有限责任公司 and GNI Group Ltd.
R
Reveal Biosciences raised undisclosed on April 2, 2019
Investors: Intel Capital and GNI Group Ltd.
C
Cullgen Inc. raised undisclosed on March 1, 2018
Investors: GNI Group Ltd.